title: [Osteogenic factor in pathogenesis of vertebrogenic cardialgia].
abstract: A total of 136 patients with clinical symptoms of thoracic osteochondrosis and reflex vertebrocardiac disorders were examined. 100 of them presented with vertebrogenic cardialgia and CHD, 36 had no CHD. 56 patients with clinical symptoms of thoracic osteochondrosis and CHD received traditional therapy and a course of intraosseous blockade (IOB). 56 patients with clinical symptoms of thoracic osteochondrosis and CHD received traditional therapy and a course of paravertebral blockade (PVB). 36 patients with clinical symptoms of thoracic osteochondrosis without CHD received a course of IOB. Efficiency of therapy was assessed from dynamics of pain syndrome parameters, data of the visual analog scale, McGill and body diagram questionnaires, changes of cardiac function and heart rhythm recorded by 24-hr Holter monitoring. Therapeutic efficiency of IOB in patients with vertebrogenic cardialgia with and without CHD was higher than that of PVB in patients with clinical symptoms of thoracic osteochondrosis and CHD. It is concluded that osteogenic factor plays a key role in the mechanism of development of vertebrogenic cardialgia.
authors: E L
authors: EL
authors: Sokov
authors: L E
authors: LE
authors: Kornilova
authors: V A
authors: VA
authors: Filimonov
authors: P A
authors: PA
authors: Ganzhula
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D002637:Chest Pain / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D003937:Diagnosis, Differential; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009407:Nerve Block / Q000379:methods; D010147:Pain Measurement; D055035:Spinal Osteochondrosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011795:Surveys and Questionnaires; D013904:Thoracic Vertebrae
chemical_list: D000700:Analgesics